AIRLINK 79.41 Increased By ▲ 1.02 (1.3%)
BOP 5.33 Decreased By ▼ -0.01 (-0.19%)
CNERGY 4.38 Increased By ▲ 0.05 (1.15%)
DFML 33.19 Increased By ▲ 2.32 (7.52%)
DGKC 76.87 Decreased By ▼ -1.64 (-2.09%)
FCCL 20.53 Decreased By ▼ -0.05 (-0.24%)
FFBL 31.40 Decreased By ▼ -0.90 (-2.79%)
FFL 9.85 Decreased By ▼ -0.37 (-3.62%)
GGL 10.25 Decreased By ▼ -0.04 (-0.39%)
HBL 117.93 Decreased By ▼ -0.57 (-0.48%)
HUBC 134.10 Decreased By ▼ -1.00 (-0.74%)
HUMNL 7.00 Increased By ▲ 0.13 (1.89%)
KEL 4.67 Increased By ▲ 0.50 (11.99%)
KOSM 4.74 Increased By ▲ 0.01 (0.21%)
MLCF 37.44 Decreased By ▼ -1.23 (-3.18%)
OGDC 136.70 Increased By ▲ 1.85 (1.37%)
PAEL 23.15 Decreased By ▼ -0.25 (-1.07%)
PIAA 26.55 Decreased By ▼ -0.09 (-0.34%)
PIBTL 7.00 Decreased By ▼ -0.02 (-0.28%)
PPL 113.75 Increased By ▲ 0.30 (0.26%)
PRL 27.52 Decreased By ▼ -0.21 (-0.76%)
PTC 14.75 Increased By ▲ 0.15 (1.03%)
SEARL 57.20 Increased By ▲ 0.70 (1.24%)
SNGP 67.50 Increased By ▲ 1.20 (1.81%)
SSGC 11.09 Increased By ▲ 0.15 (1.37%)
TELE 9.23 Increased By ▲ 0.08 (0.87%)
TPLP 11.56 Decreased By ▼ -0.11 (-0.94%)
TRG 72.10 Increased By ▲ 0.67 (0.94%)
UNITY 24.82 Increased By ▲ 0.31 (1.26%)
WTL 1.40 Increased By ▲ 0.07 (5.26%)
BR100 7,526 Increased By 32.9 (0.44%)
BR30 24,650 Increased By 91.4 (0.37%)
KSE100 71,971 Decreased By -80.5 (-0.11%)
KSE30 23,749 Decreased By -58.8 (-0.25%)

UK researchers warn Covid-19 patients with mild symptoms could experience brain disorders

  • Study states coronavirus is associated with a wide spectrum of neurological syndromes that affects the whole neuraxis
Published July 8, 2020

(Karachi) UK neurologists have warned that coronavirus patients suffering mild symptoms or those recovering from the disease might experience potentially deadly brain disorder.

Publishing the paper in the journal Brain on Wednesday, neurologists said that there is an increase in a life-threatening condition called acute disseminated encephalomyelitis (Adem) during the first wave of infections in Britain.

Coronavirus vaccine to enter late-stage trial by July end: Researchers

As part of the research, British neurologists examined and analyzed 43 Covid-19 patients whose complications ranged from brain inflammation and delirium to nerve damage and stroke. The patients included 24 males and 19 females with ages ranging from 16 to 85 years. Among them, 10 patients had a parainfectious or septic encephalopathy with delirium.

The paper stated that coronavirus is associated with a wide spectrum of neurological syndromes that affects the whole neuraxis, including the cerebral vasculature and in some cases, responding to immunotherapies. However, this complication is not related to the severity of the disease.

Commenting on the matter, senior author on the study Michael Zandi said: “We’re seeing things in the way Covid-19 affects the brain that we haven’t seen before with other viruses.”

She added, “What we’ve seen with some of these Adem patients, and in other patients, is you can have severe neurology, you can be quite sick, but actually have trivial lung disease.”

Chinese researchers launch phase-2 human test for possible coronavirus vaccine

“We want clinicians around the world to be alert to these complications of coronavirus,” she mentioned.

With millions of Covid-19 deaths across the world, scientists race to develop a vaccine to prevent the virus from spreading further. Most of the renowned pharmaceutical companies globally have begun trials, some entering stage 3 trials.

So far, 547,430 people have died of the disease worldwide while 11,984,936 have been infected. Besides, 58,246 patients are in critical condition while 6,929,661 people recovered from the virus. The highest number of patients were reported in United States with 3,097,538 cases followed by Brazil with 1,674,655 infections and India with 746,506 cases.

Comments

Comments are closed.